Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

14.91
Delayed Data
As of Sep 02
 +0.63 / +4.41%
Today’s Change
5.13
Today|||52-Week Range
18.83
+79.21%
Year-to-Date

Today’s Trading

Previous close14.28
Today’s open14.70
Day’s range14.23 - 14.92
Volume1,789,326
Average volume (3 months)2,316,315
Market cap$1.7B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+19.83%
Earnings growth (this year)-27.34%
Earnings growth (next 5 years)--
Revenue growth (last year)+237.19%
P/E ratioNM
Price/Sales506.03
Price/Book11.17

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+2.01+3.70%
ALDRAlder Biopharmaceuti...+2.29+5.94%
THRXTheravance Inc+1.10+7.69%
LCILannett Company Inc+2.19+4.63%
Data as of 4:01pm ET, 09/02/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$1.2M
Annual profit (last year)-$68.9M
Net profit margin-5,631.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts

Partner Offers